000 01520 a2200397 4500
005 20250515025423.0
264 0 _c20061108
008 200611s 0 0 eng d
022 _a0007-1048
024 7 _a10.1111/j.1365-2141.2006.06097.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAl-Ahmari, Ali
245 0 0 _aLong-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
_h[electronic resource]
260 _bBritish journal of haematology
_cJun 2006
300 _a646-8 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aCytarabine
_xadministration & dosage
650 0 4 _aDiterpenes
650 0 4 _aDown Syndrome
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aEpidemiologic Methods
650 0 4 _aHumans
650 0 4 _aLeukemia, Megakaryoblastic, Acute
_xdrug therapy
650 0 4 _aRetinyl Esters
650 0 4 _aTreatment Outcome
650 0 4 _aVincristine
_xadministration & dosage
650 0 4 _aVitamin A
_xadministration & dosage
700 1 _aShah, Niketa
700 1 _aSung, Lillian
700 1 _aZipursky, Alvin
700 1 _aHitzler, Johann
773 0 _tBritish journal of haematology
_gvol. 133
_gno. 6
_gp. 646-8
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.2006.06097.x
_zAvailable from publisher's website
999 _c16303966
_d16303966